- Home
- KYTX vs CRMT Comparison
KYTX vs CRMT Comparison
Compare KYTX & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYTX
- CRMT
- Stock Information
- Founded
- KYTX 2018
- CRMT 1981
- Country
- KYTX United States
- CRMT United States
- Employees
- KYTX N/A
- CRMT N/A
- Industry
- KYTX
- CRMT Other Specialty Stores
- Sector
- KYTX
- CRMT Consumer Discretionary
- Exchange
- KYTX NYSE
- CRMT Nasdaq
- Market Cap
- KYTX 242.1M
- CRMT 270.3M
- IPO Year
- KYTX 2024
- CRMT N/A
- Fundamental
- Price
- KYTX $3.99
- CRMT $43.07
- Analyst Decision
- KYTX Buy
- CRMT Hold
- Analyst Count
- KYTX 5
- CRMT 3
- Target Price
- KYTX $23.20
- CRMT $50.00
- AVG Volume (30 Days)
- KYTX 248.8K
- CRMT 80.1K
- Earning Date
- KYTX 11-13-2024
- CRMT 12-05-2024
- Dividend Yield
- KYTX N/A
- CRMT N/A
- EPS Growth
- KYTX N/A
- CRMT N/A
- EPS
- KYTX N/A
- CRMT N/A
- Revenue
- KYTX N/A
- CRMT $1,369,964,000.00
- Revenue This Year
- KYTX N/A
- CRMT N/A
- Revenue Next Year
- KYTX N/A
- CRMT $3.19
- P/E Ratio
- KYTX N/A
- CRMT N/A
- Revenue Growth
- KYTX N/A
- CRMT N/A
- 52 Week Low
- KYTX $3.94
- CRMT $37.98
- 52 Week High
- KYTX $30.60
- CRMT $83.07
- Technical
- Relative Strength Index (RSI)
- KYTX 30.54
- CRMT 55.10
- Support Level
- KYTX $3.94
- CRMT $40.80
- Resistance Level
- KYTX $4.34
- CRMT $43.65
- Average True Range (ATR)
- KYTX 0.38
- CRMT 1.37
- MACD
- KYTX -0.10
- CRMT 0.32
- Stochastic Oscillator
- KYTX 2.99
- CRMT 82.73
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
About CRMT America's Car-Mart Inc
America's Car-Mart Inc is an automotive retailer in us focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The Company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It primarily sells older model used vehicles and provides financing for substantially all of its customers. The Company earns revenue from the sale of used vehicles and in most cases a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.